stoxline Quote Chart Rank Option Currency Glossary
  
Achieve Life Sciences, Inc. (ACHV)
3.015  0.285 (10.44%)    05-16 13:59
Open: 2.69
High: 3.04
Volume: 347,576
  
Pre. Close: 2.73
Low: 2.68
Market Cap: 105(M)
Technical analysis
2025-05-16 1:45:04 PM
Short term     
Mid term     
Targets 6-month :  3.55 1-year :  4.14
Resists First :  3.03 Second :  3.55
Pivot price 2.53
Supports First :  2.36 Second :  1.95
MAs MA(5) :  2.67 MA(20) :  2.49
MA(100) :  2.91 MA(250) :  3.98
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  79.6 D(3) :  72.5
RSI RSI(14): 64.1
52-week High :  5.59 Low :  1.84
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ ACHV ] has closed above the upper band by 21.0%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.73 - 2.74 2.74 - 2.76
Low: 2.46 - 2.47 2.47 - 2.49
Close: 2.71 - 2.73 2.73 - 2.75
Company Description

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.

Headline News

Wed, 14 May 2025
Raymond James Financial Inc. Purchases New Position in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - MarketBeat

Wed, 14 May 2025
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q1 2025 Earnings Call Transcript - Insider Monkey

Wed, 14 May 2025
Achieve Life Sciences Inc (ACHV) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance

Wed, 14 May 2025
Achieve Life Sciences Inc (ACHV) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus

Tue, 13 May 2025
Transcript : Achieve Life Sciences, Inc., Q1 2025 Earnings Call, May 13, 2025 - marketscreener.com

Tue, 13 May 2025
ACHIEVE LIFE SCIENCES Earnings Results: $ACHV Reports Quarterly Earnings - Nasdaq

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 35 (M)
Shares Float 29 (M)
Held by Insiders 9.8 (%)
Held by Institutions 46.9 (%)
Shares Short 2,500 (K)
Shares Short P.Month 3,030 (K)
Stock Financials
EPS -1.25
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.6
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -84.2 %
Return on Equity (ttm) -409.6 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -1.12
Qtrly Earnings Growth 0 %
Operating Cash Flow -30 (M)
Levered Free Cash Flow -18 (M)
Stock Valuations
PE Ratio -2.43
PEG Ratio 0
Price to Book value 5.01
Price to Sales 0
Price to Cash Flow -3.51
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android